BIT
BIO icon

BlackRock Institutional Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

BlackRock Institutional Trust’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$116M Buy
636,888
+19,041
+3% +$3.25M 0.02% 838
2016
Q3 		$101M Sell
617,847
-15,382
-2% -$2.33M 0.02% 866
2016
Q2 		$90.6M Buy
633,229
+21,591
+4% +$3.08M 0.01% 903
2016
Q1 		$83.6M Sell
611,638
-1,256
-0.2% -$165K 0.01% 937
2015
Q4 		$85M Buy
612,894
+34
+0% +$4.71K 0.01% 926
2015
Q3 		$82.3M Sell
612,860
-16,408
-3% -$2.36M 0.01% 946
2015
Q2 		$94.8M Buy
629,268
+30,279
+5% +$4.33M 0.02% 920
2015
Q1 		$81M Buy
598,989
+42,972
+8% +$5.33M 0.01% 1050
2014
Q4 		$67M Buy
556,017
+2,204
+0.4% +$254K 0.01% 1106
2014
Q3 		$62.8M Sell
553,813
-20,995
-4% -$2.49M 0.01% 1118
2014
Q2 		$68.8M Sell
574,808
-13,491
-2% -$1.65M 0.01% 1107
2014
Q1 		$75.4M Sell
588,299
-121,960
-17% -$15.6M 0.01% 1041
2013
Q4 		$87.8M Buy
710,259
+168,669
+31% +$20.6M 0.02% 922
2013
Q3 		$63.7M Sell
541,590
-96,539
-15% -$11.4M 0.01% 1047
2013
Q2 		$71.6M Buy
+638,129
New +$74.9M 0.01% 942

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

BlackRock Institutional Trust's BIO Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Bio-Rad Laboratories Class A (BIO) stake by 3.1% in Q4 2016, buying an estimated $3.25M and bringing the position to 636,888 shares worth $116M. The position accounts for 0.02% of the portfolio, ranked #838.

BlackRock Institutional Trust first reported a position in BIO in Q2 2013 and has held it in 15 quarters since. 260 funds tracked by Wall St. Rank hold BIO as of Q4 2016.

  • BlackRock Institutional Trust held 636,888 shares of Bio-Rad Laboratories Class A worth $116M as of Q4 2016.
  • BlackRock Institutional Trust bought 19,041 Bio-Rad Laboratories Class A shares in Q4 2016, an estimated $3.25M.
  • Bio-Rad Laboratories Class A made up 0.02% of BlackRock Institutional Trust's portfolio in Q4 2016, its #838 holding.
  • BlackRock Institutional Trust first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 15 quarters since.
  • 260 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.